Drugmaker Teva lowers 2017 outlook again after third quarter earnings fall

JERUSALEM (Reuters) - Teva Pharmaceutical Industries, the world's biggest generic medicine maker, warned on 2017 earnings on Thursday after reporting a fall in third-quarter profit hurt by competition in the U.S. market.